Elnusa Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Elnusa Tbk. trades at Rp725 (market cap 5.33T, 33.14M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Elnusa Tbk. is far larger — about 51.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| ELSA | SCPI | |
|---|---|---|
Market Cap | 5.33T | 104.4B |
Volume | 33.14M | — |
Lot | 331.38K | — |
Turnover | 24.44B | — |
Average Price | 737.47 | — |
Value | 24.44B | — |
Indicative Equilibrium Price | 725 | — |
Indicative Equilibrium Volume | 24.27K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Elnusa Tbk (Company) was established under the name of PT Elektronika Nusantara on January 25, 1969 based on notarial deed No.18 of Tan Thong Kie, S.H., dated January 25, 1969, as amended by notarial deed No. 10 of the same notary dated February 13, 1969. The Company’s articles of association has been amended several times, most recently by notarial deed No. 2 of Soegeng Santosa, S.H., dated Jan 7, 2002, concerning among others, the change in the Company’s name and public offering.
Read more on ELSA →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →